nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

3. Periprozedurale Komplikationen

verfasst von : Erhard Kaiser, Jan Pollmann, Carsten Skurk, Martin Müller

Erschienen in: Komplikationsmanagement im Herzkatheterlabor

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die diagnostischen und therapeutischen Möglichkeiten im Herzkatheterlabor ergeben sich erst aus der Applikation jodhaltigen Röntgenkontrastmittels und der Visualisierung mittels Röntgenstrahlung. Betrachtet man das applizierte Röntgenkontrastmittel als eine Art Medikament, so wird leicht verständlich, dass neben der erwünschten Wirkung auch unerwünschte Wirkungen auftreten können

Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Dovellini EV, Santoro GM (2002) Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90(4):353–357

Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, O'Neill Md WW (2018) Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv 91(3):454–461

Berwanger O (2010) Acetylcysteine for the Prevention of Contrast-Induced Nephropathy (ACT) Trial: a pragmatic multicenter randomized trial to evaluate the efficacy of acetylcysteine for the prevention of renal outcomes in patients undergoing coronary and vascular angiography, Abstract 21843, Tuesday, November 16, 11:51–12:01. American Heart Association’s Scientific Sessions

Blomberg H, Gedeborg R, Berglund L, Karlsten R, Johansson J (2011) Poor chest compression quality with mechanical compressions in simulated cardiopulmonary resuscitation: a randomized, cross-over manikin study. Resuscitation 82(10):1332–1337CrossRef

Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG (2002) Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 89(2):132–136

De Backer D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–789CrossRef

de Waha, S., Fuernau, G., Eitel, I., Desch, S., & Thiele, H. (2016). Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort. EuroIntervention, 12(3):414

Enright T et al (1989) Ann Allergy 62(4):302–305PubMed

Esposito ML, Zhang Y, Qiao X, Reyelt L, Paruchuri V, Schnitzler GR, Kapur NK (2018) Left Ventricular Unloading Before Reperfusion Promotes Functional Recovery After Acute Myocardial Infarction. J Am Coll Cardiol 72(5):501–514

Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, Investigators S (2004) Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44(2):340–348

Flaherty MP, Khan AR, O’Neill WW (2017) Early Initiation of Impella in Acute Myocardial Infarction Complicated by Cardiogenic Shock Improves Survival: A Meta-Analysis. JACC Cardiovasc Interv 10(17):1805–1806

Gertz EW et al (1992) J Am Coll Cardiol 19(5):899–906CrossRef

Goss JE et al (1995) Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: Guidelines for prevention, diagnosis, and treatment. Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 34(2):99–104CrossRef

Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with preexistent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548CrossRef

Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, Network G (2015) Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 17(5):501–509

Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr (2000) Cardiogenic shock complicating acute coronary syndromes. Lancet 356:749–756CrossRef

Hintze G et al (1999) Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol 140(3):264–267CrossRef

Hochman JS, Sleeper, LA, Webb JG, Sanborn TA, White HD, Talley JD, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341(9):625–634

Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, LeJemtel T (2000). Cardiogenic shock complicating acute myocardial infarction–etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1063–1070

Hochman JS, Sleeper LA, Webb JG, Dzavik V, Bulle, CE, Aylward P, Investigators S (2006) Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295(21):2511–2515

Hollenberg SM (2001) Cardiogenic shock. Crit Care Clin 17:391–410CrossRef

Hollenberg SM, Kavinsky CJ, Parrillo JE (1999) Cardiogenic shock. Ann Intern Med 131:47–59CrossRef

Hoste EA, De Waele JJ, Gevaert SA et al (2009) Sodium bicarbonate for prevention of contrast- induced acute kidney injury: a systemic review and meta-analysis. Nephrol Dial Transplant 25(3):747–758CrossRef

Ibanez B, Halvorsen S, Roffi M, Bueno H, Thiele H, Vranckx P, James S (2018a) Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force. Eur Heart J 39(48):4239–4242

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Group ESCSD (2018b) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177

International Collaborative Study of Severe Anaphylaxis (2003) Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an internationalstudy. Pharmacoepidemiolog Drug Saf 12(3):195–202

Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, Investigators S (2006) Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J 27(6):664–670

Kane GC, Doyle BJ, Lerman A et al (2008) Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angio- graphy. J Am Coll Cardiol 51:89–90CrossRef

Kapur NK, Davila CD (2017) Timing, timing, timing: the emerging concept of the ‘door to support’ time for cardiogenic shock. Eur Heart J 38(47):3532–3534

Kapur NK, Paruchuri V, Urbano-Morales JA, Mackey EE, Daly GH, Qiao X, Karas RH (2013) Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation, 128(4):328–336

Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P (2011) The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 57(6):688–696

Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 256:21–28CrossRef

Kelly AM, Dwamena B, Cronin P et al (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148:284–294CrossRef

Koreny M, Karth GD, Geppert A et al (2002) Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 112:115–119CrossRef

Kotoku M, Tamura A, Naono S, Kadota J (2007) Sinus arrest caused by occlusion of the sinus node artery during percutaneous coronary intervention for lesions of the proximal right coronary artery. Heart Vessels 22(6):389–392CrossRef

Kuchibhotla S, Esposito ML, Breton C, Pedicini R, Mullin A, O'Kelly R, Kapur NK (2017) Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock. J Am Heart Assoc 6(10)

Larsen AI, Hjørnevik A, Bonarjee V, Barvik S, Melberg T, Nilsen DW (2010) Coronary blood flow and perfusion pressure during coronary angiography in patients with ongoing mechanical chest compression: a report on 6 cases. Resuscitation 81(4):493–497CrossRef

Latasch L, Knipfer E (2004) Allgemeinanästhesieverfahren. In: Latasch L, Knipfer E (Hrsg) Anästhesie, Intensivmedizin, Intensivpflege. Elsevier, München, S 324–330

Lembo NJ, King SB 3rd, Roubin GS, Black AJ, Douglas JS Jr. (1991) Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty. Am J Cardiol 67(13):1046–1050CrossRef

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Collaborators. (2018) Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 72(2):173–182

McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006) A metaanalysis of the renal safety of isosmolar iodixanol compared with lower molar contrast media. J Am Coll Cardiol 48:692–699CrossRef

Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int 69:11–15CrossRef

Mehran R, Aymong EO, Nikolsky E et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed

Menon V, Fincke R (2003) Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail 9(1):35–39CrossRef

Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS (2000) The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36:1071–1076CrossRef

Metra M, Nodari S, D’Aloia A et al (2002) Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am Coll Cardiol 40:1248–1258CrossRef

Moiseyev VS, Poder P, Andrejevs N et al (2002) Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 23:1422–1432CrossRef

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Group ESCSD (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87–165

Nolan JP et al (2010) European resuscitation council guidelines for resuscitation 2010. Resuscitation 81:1219–1276CrossRef

Nolte MR et al (1996) Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 134(3):337–341CrossRef

O’Neill WW, Schreiber T, Wohns DH, Rihal C, Naidu SS, Civitello AB, Ohman EM (2014) The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 27(1):1–11

O’Neill W, Basir M, Dixon S, Patel K, Schreiber T, Almany S (2017) Feasibility of Early Mechanical Support During Mechanical Reperfusion of Acute Myocardial Infarct Cardiogenic Shock. JACC Cardiovasc Interv 10(6):624–625

Ocker H, Semmel T (2011) Der Larynxtubus in der Notfallmedizin: Eine praxisorientierte Anwendungsanleitung. http://www.vbm-medical.de/cms/files/a5-1.0_06.08-de--web--.pdf. Zugegriffen: Sept. 2011

Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Kastrati A (2014) Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction Results of the ISAR-SHOCK registry. Thromb Haemos 112(6):1190–1197

Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Henriques JP (2017) Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol, 69(3):278–287

Pancholy SB, Palamaner Subash Shantha G, Romagnoli E, Kedev S, Bernat I, Rao SV, Patel TM (2015) Impact of access site choice on outcomes of patients with cardiogenic shock undergoing percutaneous coronary intervention: A systematic review and meta-analysis. Am Heart J 170(2):353–361

Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Westermann D (2017) Concomitant implantation of Impella((R)) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 19(3):404–412

Parodi G, Xanthopoulou I, Bellandi B, Gkiza V, Valenti R, Karanikas S, Alexopoulos D (2015) Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study. J Am Coll Cardiol 65(5):511–512

Patti G, Nusca A, Chello M et al (2008) Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardio 101:279–285CrossRef

Persson BP, Tepel M (2006) Contrast medium-induced nephropathy: the pathophysiology. Kidney Int 69:8–10CrossRef

Rab T, Ratanapo S, Kern KB, Basir MB, McDaniel M, Meraj P, O’Neill W (2018) Cardiac Shock Care Centers: JACC Review Topic of the Week. J Am Coll Cardiol 72(16):1972–1980

Rathod KS, Koganti S, Iqbal MB, Jain AK, Kalra SS, Astroulakis Z, Jones DA (2018) Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. Eur Heart J Acute Cardiovasc Care 7(1):16–27

Ring J et al (1985) Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 78(1):9–14CrossRef

Sandler CM (2003) Contrast-agent induced acute renal dysfunction – is iodixanol the answer? N Engl J Med 348(6):551–553CrossRef

Schonenberger E, Muhler M, Dewey M (2010) Komplikationen durch Kontrastmittelgabe. Was ist gesichert in der Prävention? Internist (Berl.) 51:1516–1524CrossRef

Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Westermann D (2019) Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation 139(10):1249–1258

Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Schomig A (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588

Stretch R, Sauer CM, Yuh DD, Bonde P (2014) National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64(14):1407–1415

Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, O’Connor, CM (2019) Standardized Team-Based Care for Cardiogenic Shock. J Am Coll Cardiol 73(13):1659–1669

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Investigators I-SIT (2012). Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296

Thiele H, Ohman EM, Desch S, Eitel I, de Waha S (2015). Management of cardiogenic shock. Eur Heart J 36(20):1223–1230

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Investigators C-S (2017a) PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med 377(25):2419–2432

Thiele H, Jobs A, Ouweneel DM, Henriques JPS, Seyfarth M, Desch S, de Waha S (2017b) Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 38(47):3523–3531

Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta RadioI 49:646–657CrossRef

van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Mission L (2017) Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation 136(16):e232–e268

Wagner H, Terkelsen CJ, Friberg H, Harnek J, Kern K, Lassen JF, Olivecrona GK (2010) Cardiac arrest in the catheterisation laboratory: a 5-year experience of using mechanical chest compressions to facilitate PCI during prolonged resuscitation efforts. Resuscitation 81(4):383–387CrossRef

Yamaguchi K et al (1991) Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 178(2):363–367CrossRef

Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik, M, Arbeitsgemeinschaft Leitende Kardiologische K (2004) Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 25(4):322–328

Analgosedierung für diagnostische und therapeutische Maßnahmen bei Erwachsenen. http://www.dgai.de/eev/EEV_2011_S_121-128.pdf. Zugegriffen: Aug. 2012

Fachinformationen zu Clorazepat, Etomidate, Ketamin, Midazolam, Propofol, Remifentanil, Rocuronium, Sugammadex, Tranxillium und Ultiva: http://ch.oddb.org

Gebrauchsinformation Ketanest S. http://static.pfizer.de/fileadmin/pfizer.de/documents/gi/KetanestS_5-5_GI.pdf. Zugegriffen: Aug. 2012

Larynx-Tubus in der Notfallmedizin. http://www.vbm-medical.de/cms/files/a5-1.0_06.08-de--web--.pdf. Zugegriffen: Aug. 2012

Perioperatives Nüchternheitsgebot bei operativen Eingriffen. http://www.dgai.de/eev/EEV_2011_S_93-94.pdf. Zugegriffen: Aug. 2012

Titel: Periprozedurale Komplikationen
verfasst von: Erhard Kaiser
Jan Pollmann
Carsten Skurk
Martin Müller
Verlag: Springer Berlin Heidelberg
Buch: Komplikationsmanagement im Herzkatheterlabor
Print ISBN: 978-3-662-55975-8

Electronic ISBN: 978-3-662-55976-5

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-55976-5_3

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

3. Periprozedurale Komplikationen

Zusammenfassung

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie